DP-R208 Pharmacokinetic Study

NCT02709187 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: DP-R208
DRUG: Candesartan cilexetil
DRUG: Rosuvastatin

Sponsor

Alvogen Korea